The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia
{{output}}
Background: In patients with myeloproliferative neoplasia (MPN) the development of fibrosis and increased vessel density correlate with poor prognosis. The JAK2(V617F) mutation constitutively activates JAK2, which phosphorylates ... ...
